However, while overexpression of miR-200a expression decreases p38α/MAPK14 protein in ovarian adenocarcinomas and promotes tumorigenesis, it enhances tumor cell death and slows tumor growth under treatment with paclitaxel (Taxane family group) (Mateescu et al. 2011). The gene discussed is MAPK14; the disease is neoplasm.